The function of genetic modifiers of NR2E3, such as the nuclear hormone receptor Nr1d1 (Rev-erbα), has been explored as a therapeutic option in the NR2E3-associated retinal disease, rd7, mouse model.26 The gene discussed is NR1D1; the disease is Abnormal retinal morphology.